The protective effect of IFN-γ in experimental autoimmune diseases: A central role of mycobacterial adjuvant-induced myelopoiesis

Journal of Leukocyte Biology

Volumn 68, Issue 4, 2000, Pages 447-454

  Matthys, P ^a   Vermeire, K ^a   Heremans, H ^a   Billiau, A ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Autoimmunity; Freund's adjuvant; Hematopoiesis; Mycobacterium

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GAMMA INTERFERON RECEPTOR;

ANIMAL MODEL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; MYCOBACTERIUM; MYELOPOIESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; RHEUMATOID ARTHRITIS;

ANIMAL; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; DISEASE MODELS, AUTOIMMUNE, NERVOUS SYSTEM; FREUND'S ADJUVANT; HEMATOPOIESIS; HISTOCOMPATIBILITY ANTIGENS; HUMAN; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; NITRIC OXIDE; RECEPTORS, INTERFERON; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTE SUBSETS; UVEITIS;

EID: 0033780297     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Interferon-γ: Biology- and role in pathogenesis
2. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice
3. Prevention of diabetes in NOD mice treated with antibody to routine IFNγ
4. Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-γ antibody
5. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ
6. Postnatal anti-interferon-γ treatment prevents pancreatic inflammation in transgenic mice with β-cell expression of interferon-γ
7. Induction of vascular addressins and adhesion molecules in the pancreas of IFN-γ transgenic mice
8. Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by intefferon-γ plus tumor necrosis factor-α
9. Contribution of ductal cells to cytokine responses by human pancreatic islets
10. Mice with IFN-γ receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis
11. Interferon-γ(IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice
12. IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZBxN-ZW)F1 mice
13. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ
14. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: Enhancement by monoclonal antibodies against IFN-γ
15. Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains
16. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse
17. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
18. Interferon-γ confers resistance to experimental allergic encephalomyelitis
19. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
20. Endogenous systemic IFN-γ has a protective role against ocular autoimmunity in mice
21. Immune modulation within the brain: Recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-γ
22. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation
23. Intefferon-γ potentiates antibody-mediated demyelination in vivo
24. Targeted CNS expression of interferon-γ in transgenie mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development
25. Primary demyelination in transgenic mice expressing interferon-γ
26. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE
27. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
28. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction
29. IFN-γ is critical to the control of routine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
30. IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines
31. IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response
32. Interferon-γ at the systemic level protects mice against experimental autoimmune uveoretinitis
33. + myeloid cells
34. Accelerated collagen-induced arthritis in interferon-γ receptor-deficient mice
35. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors
36. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-γ
37. Immune response in mice that lack the interferon-γ receptor
38. An essential role for interferon γ in resistance to Mycobacteriura tuberculosis infection
39. The stimulator effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon-γ in vivo
40. Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis
41. Hematopoietic remodelling in interferon-γ-deficient mice infected with mycobacteria
42. The biology of interleukin-6
43. The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis (EAT): Prevention of disease and decrease of EAT-specific T cells
44. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-γ receptor gene
45. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leucocyte extravasation from blood, are prevented in macrophage-depleted mice
46. The mode of action of immunologic adjuvants
47. 125I-labelled Salmonella adelaide flagellin following injection into the rat in the presence of Freund's complete adjuvant
48. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response
49. Increased bone marrow production of granulocytes and mononuclear phagocytes induced by mycobacterial adjuvants: Improved recovery of leukopoiesis in mice after cyclophosphamide treatment
50. Rheumatoid arthritis: Opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs
51. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-γ antibody
52. IFN-γ-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids
53. Increased susceptibility to immunologically mediated glomerulonephritis in IFN-γ-deficient mice
54. Essential pathogenic role for endogenous interferon-γ (IFN-γ) during disease onset phase of murine experimental autoimmune orchitis. I. In vivo studies
55. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice
56. IFN-γ receptor signalling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(1pr) mice
57. Roles of interferon-γ and interleukin-4 in murine lupus
58. Intefferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice
59. IFN-γ induces islet MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse
60. Interferon-γ impacts at multiple points during the progression of autoimmune diabetes
61. Interferon-γ is essential for destruction of β-cells and development of insulin-dependent diabetes mellitus